Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEXAVAR for Hepatocellular carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 141 adverse event reports in the FDA FAERS database where NEXAVAR was used for Hepatocellular carcinoma.

Most Reported Side Effects for NEXAVAR

Side Effect Reports % Deaths Hosp.
Diarrhoea 46 12.6% 14 18
Hepatocellular carcinoma 42 11.5% 33 12
Palmar-plantar erythrodysaesthesia syndrome 36 9.9% 16 11
Hepatic cancer 27 7.4% 9 8
Decreased appetite 24 6.6% 9 12
Hypertension 22 6.0% 8 8
Fatigue 20 5.5% 5 7
Renal cancer 20 5.5% 1 0
Rash 19 5.2% 6 6
Abdominal pain 18 4.9% 4 10
Nausea 18 4.9% 5 12
Pain in extremity 18 4.9% 3 6
Ascites 17 4.7% 10 12
Death 17 4.7% 16 4
Hepatic encephalopathy 17 4.7% 9 13

Other Indications for NEXAVAR

Hepatic cancer (103) Renal cancer (29) Renal cell carcinoma (16) Thyroid cancer (10) Metastases to lung (6)

Other Drugs Used for Hepatocellular carcinoma

ATEZOLIZUMAB (8,443) BEVACIZUMAB (7,773) LENVATINIB (5,384) SORAFENIB (4,986) CABOZANTINIB S-MALATE (2,670) DURVALUMAB (1,255) NIVOLUMAB (1,142) REGORAFENIB (1,050) TREMELIMUMAB\TREMELIMUMAB-ACTL (589) PEMBROLIZUMAB (518)

Related Pages

NEXAVAR Full Profile All Hepatocellular carcinoma Drugs NEXAVAR Demographics NEXAVAR Timeline